Nasal Immunotherapy in Weed-Induced Allergic Rhinitis (Q73716479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9305235 AND SRC:MED&resulttype=core&format=json

6 November 2019

title

Nasal immunotherapy in weed-induced allergic rhinitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9305235 AND SRC:MED&resulttype=core&format=json

6 November 2019

Nasal Immunotherapy in Weed-Induced Allergic Rhinitis (English)

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

17 November 2024

1 reference

1 reference

B. Gaglani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9305235

17 November 2024

L. Borish

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9305235

17 November 2024

B. L. Bartelson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9305235

17 November 2024

A. Buchmeier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9305235

17 November 2024

L. Keller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9305235

17 November 2024

H. S. Nelson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9305235

17 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9305235

17 November 2024

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9305235 AND SRC:MED&resulttype=core&format=json

6 November 2019

September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9305235

full work available at URL

17 November 2024

https://api.elsevier.com/content/article/PII:S1081120610630128?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

https://api.elsevier.com/content/article/PII:S1081120610630128?httpAccept=text/plain

17 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

Annals of Allergy, Asthma & Immunology

17 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9305235 AND SRC:MED&resulttype=core&format=json

6 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9305235 AND SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9305235 AND SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

259-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9305235 AND SRC:MED&resulttype=core&format=json

Local intranasal immunotherapy for ragweed allergic rhinitis I. Clinical response

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Preseasonal intranasal immunotherapy with nebulized short ragweed extract

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Local intranasal immunotherapy with high-dose polymerized ragweed extract

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Local nasal immunotherapy in allergic rhinitis to Parietaria. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Specific IgE, IgG, and IgA antibody response to oral immunotherapy in birch pollinosis

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Safety and efficacy of oral immunotherapy with standardized cat extract

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Allergen immunotherapy decreases interleukin 4 production in CD4 T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Maintenance of clonal anergy by endogenously produced IL-10

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Interleukin-10 regulation in normal subjects and patients with asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Human interleukin 10 induces naive surface immunoglobulin D (sIgD ) B cells to secrete IgG1 and IgG3

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)63012-8

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9305235 AND SRC:MED&resulttype=core&format=json

6 November 2019

1 reference